Journal articles on the topic 'Fibrosis regression'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Fibrosis regression.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Landge, Karishma, Vineeta Ojha, KartikP Ganga, Prateek Kaushik, Pooja Sharma, Priya Jagia, Sudheer Arava, et al. "Endomyocardial fibrosis regression." Journal of the Practice of Cardiovascular Sciences 5, no. 2 (2019): 102. http://dx.doi.org/10.4103/jpcs.jpcs_7_19.
Full textIredale, John, and Lara Campana. "Regression of Liver Fibrosis." Seminars in Liver Disease 37, no. 01 (February 15, 2017): 001–10. http://dx.doi.org/10.1055/s-0036-1597816.
Full textAndrade, Zilton A. "Schistosomiasis and hepatic fibrosis regression." Acta Tropica 108, no. 2-3 (November 2008): 79–82. http://dx.doi.org/10.1016/j.actatropica.2008.04.003.
Full textSato, Masaaki, David M. Hwang, Zehong Guan, Jonathan C. Yeung, Masaki Anraku, Dirk Wagnetz, Shin Hirayama, Thomas K. Waddell, Mingyao Liu, and Shaf Keshavjee. "Regression of Allograft Airway Fibrosis." American Journal of Pathology 179, no. 3 (September 2011): 1287–300. http://dx.doi.org/10.1016/j.ajpath.2011.05.032.
Full textSaffioti, Francesca, and Massimo Pinzani. "Development and Regression of Cirrhosis." Digestive Diseases 34, no. 4 (2016): 374–81. http://dx.doi.org/10.1159/000444550.
Full textCaligiuri, Alessandra, Alessandra Gentilini, Mirella Pastore, Stefano Gitto, and Fabio Marra. "Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression." Cells 10, no. 10 (October 15, 2021): 2759. http://dx.doi.org/10.3390/cells10102759.
Full textChen, Li, David A. Brenner, and Tatiana Kisseleva. "Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis." Hepatology Communications 3, no. 2 (December 13, 2018): 180–92. http://dx.doi.org/10.1002/hep4.1290.
Full textElsharkawy, Aisha, Reham Samir, and Mohamed El-Kassas. "Fibrosis regression following hepatitis C antiviral therapy." World Journal of Hepatology 14, no. 6 (June 27, 2022): 1120–30. http://dx.doi.org/10.4254/wjh.v14.i6.1120.
Full textZOIS, C. D., G. H. BALTAYIANNIS, P. KARAYIANNIS, and E. V. TSIANOS. "Systematic review: hepatic fibrosis - regression with therapy." Alimentary Pharmacology & Therapeutics 28, no. 10 (November 2008): 1175–87. http://dx.doi.org/10.1111/j.1365-2036.2008.03840.x.
Full textAmital, H. "Fibrosis regression induced by intravenous gammaglobulin treatment." Annals of the Rheumatic Diseases 62, no. 2 (February 1, 2003): 175–77. http://dx.doi.org/10.1136/ard.62.2.175.
Full textBourlière, M., A. Kahloun, and G. Gascou-Tessonnier. "Analogs and fibrosis regression in hepatitis B." Gastroentérologie Clinique et Biologique 33, no. 10-11 (October 2009): 923–29. http://dx.doi.org/10.1016/j.gcb.2009.06.003.
Full textAkarca, U. S. "Analogs and fibrosis regression in hepatitis B." Gastroentérologie Clinique et Biologique 34, no. 6-7 (August 2010): 419. http://dx.doi.org/10.1016/j.gcb.2010.03.010.
Full text&NA;. "Regression of myocardial fibrosis seen with lisinopril." Inpharma Weekly &NA;, no. 1259 (October 2000): 19. http://dx.doi.org/10.2165/00128413-200012590-00051.
Full textSood, Vikrant, Bikrant Bihari Lal, Archana Rastogi, Rajeev Khanna, Dinesh Rawat, and Seema Alam. "Regression of fibrosis in pediatric liver diseases." Indian Journal of Gastroenterology 37, no. 3 (May 2018): 266–70. http://dx.doi.org/10.1007/s12664-018-0847-8.
Full textMagdaleno, Fernando, and Jonel Trebicka. "Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression." Gut 66, no. 9 (February 28, 2017): 1540–41. http://dx.doi.org/10.1136/gutjnl-2016-313621.
Full textTakemura, Shigekazu, Hideki Azuma, Mayuko Osada-Oka, Shoji Kubo, Toshihiko Shibata, and Yukiko Minamiyama. "S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats." American Journal of Physiology-Gastrointestinal and Liver Physiology 314, no. 2 (February 1, 2018): G150—G163. http://dx.doi.org/10.1152/ajpgi.00023.2017.
Full textBrown, Ashley, and Zachary Goodman. "Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs." Expert Review of Gastroenterology & Hepatology 6, no. 2 (April 2012): 187–98. http://dx.doi.org/10.1586/egh.12.4.
Full textHorn, Angelika, Trayana Kireva, Katrin Palumbo-Zerr, Clara Dees, Michal Tomcik, Cinzia Cordazzo, Pawel Zerr, et al. "Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis." Annals of the Rheumatic Diseases 71, no. 5 (March 8, 2012): 785–89. http://dx.doi.org/10.1136/annrheumdis-2011-200883.
Full textAl-Sayegh, Rola, Santia Diab, Ghewa El-Achkar, Wared Nour-Eldine, Eva Hamade, Sophie Lotersztajn, and Aida Habib. "THU-061-Statins reduces liver fibrosis progression and promotes fibrosis regression in mice." Journal of Hepatology 70, no. 1 (April 2019): e187. http://dx.doi.org/10.1016/s0618-8278(19)30342-1.
Full textDees, Clara, Pawel Zerr, Michal Tomcik, Christian Beyer, Angelika Horn, Alfiya Akhmetshina, Katrin Palumbo, et al. "Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis." Arthritis & Rheumatism 63, no. 5 (April 27, 2011): 1396–404. http://dx.doi.org/10.1002/art.30254.
Full textOhkoshi, Shogo, Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Kenya Kamimura, and Masahiko Yano. "Natural regression of fibrosis in chronic hepatitis B." World Journal of Gastroenterology 22, no. 24 (2016): 5459. http://dx.doi.org/10.3748/wjg.v22.i24.5459.
Full textLo, Regina C., and Haeryoung Kim. "Histopathological evaluation of liver fibrosis and cirrhosis regression." Clinical and Molecular Hepatology 23, no. 4 (December 25, 2017): 302–7. http://dx.doi.org/10.3350/cmh.2017.0078.
Full textKisseleva, Tatiana, and David A. Brenner. "Inactivation of myofibroblasts during regression of liver fibrosis." Cell Cycle 12, no. 3 (February 2013): 381–82. http://dx.doi.org/10.4161/cc.23549.
Full textMabire, Morgane, Hegde Pushpa, Manon Allaire, Al Sayegh Rola, JingHong Wan, Emmanuel Weiss, Richard Moreau, Hélène Gilgenkrantz, De La Grange Pierre, and Sophie Lotersztajn. "Blocking MAIT cell activation accelerates liver fibrosis regression." Journal of Hepatology 73 (August 2020): S85—S86. http://dx.doi.org/10.1016/s0168-8278(20)30720-0.
Full textEllis, Elizabeth L., and Derek A. Mann. "Clinical evidence for the regression of liver fibrosis." Journal of Hepatology 56, no. 5 (May 2012): 1171–80. http://dx.doi.org/10.1016/j.jhep.2011.09.024.
Full textFriedman, S. L. "Fibrogenic cell reversion underlies fibrosis regression in liver." Proceedings of the National Academy of Sciences 109, no. 24 (May 29, 2012): 9230–31. http://dx.doi.org/10.1073/pnas.1206645109.
Full textKisseleva, Tatiana, and David A. Brenner. "Anti-fibrogenic strategies and the regression of fibrosis." Best Practice & Research Clinical Gastroenterology 25, no. 2 (April 2011): 305–17. http://dx.doi.org/10.1016/j.bpg.2011.02.011.
Full textSchuppan, Detlef, Rambabu Surabattula, and Xiao Yu Wang. "Determinants of fibrosis progression and regression in NASH." Journal of Hepatology 68, no. 2 (February 2018): 238–50. http://dx.doi.org/10.1016/j.jhep.2017.11.012.
Full textMehal, Wajahat, and Uyen To. "New approaches for fibrosis regression in alcoholic cirrhosis." Hepatology International 10, no. 5 (July 26, 2016): 773–78. http://dx.doi.org/10.1007/s12072-016-9752-3.
Full textKarsdal, Morten A., Sara T. Hjuler, Yi Luo, Daniel G. K. Rasmussen, Mette J. Nielsen, Signe Holm Nielsen, Diana J. Leeming, et al. "Assessment of liver fibrosis progression and regression by a serological collagen turnover profile." American Journal of Physiology-Gastrointestinal and Liver Physiology 316, no. 1 (January 1, 2019): G25—G31. http://dx.doi.org/10.1152/ajpgi.00158.2018.
Full textStoian, Marilena, and Victor Stoica. "Current Trends on Glomerulosclerosis Regression." Journal of Medicine and Life 13, no. 2 (April 2020): 116–18. http://dx.doi.org/10.25122/jml-2020-0006.
Full textSoliman, Hanan, Dina Ziada, Marwa Salama, Manal Hamisa, Rehab Badawi, Nehad Hawash, Amal Selim, and Sherief Abd-Elsalam. "Predictors for Fibrosis Regression in Chronic HCV Patients after the Treatment with DAAS: Results of a Real-world Cohort Study." Endocrine, Metabolic & Immune Disorders - Drug Targets 20, no. 1 (January 7, 2020): 104–11. http://dx.doi.org/10.2174/1871530319666190826150344.
Full textYue, Zhensheng, Zijian Jiang, Bai Ruan, Juanli Duan, Ping Song, Jingjing Liu, Hua Han, and Lin Wang. "Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression." International Journal of Biological Sciences 17, no. 9 (2021): 2135–46. http://dx.doi.org/10.7150/ijbs.60056.
Full textDe Socio, G., C. Cerquaglia, V. Curigliano, C. Fonnesu, M. Giovinale, E. Verrecchia, G. M. E. Marino, L. Natale, G. B. Gasbarrini, and R. Manna. "Association between Familial Mediterranean Fever and Retroperitoneal Fibrosis: Retroperitoneal Fibrosis Regression after Colchicine Therapy." International Journal of Immunopathology and Pharmacology 22, no. 2 (April 2009): 521–24. http://dx.doi.org/10.1177/039463200902200229.
Full textWanless, Ian R., Eisuke Nakashima, and Morris Sherman. "Regression of Human Cirrhosis." Archives of Pathology & Laboratory Medicine 124, no. 11 (November 1, 2000): 1599–607. http://dx.doi.org/10.5858/2000-124-1599-rohc.
Full textChen, Chih-Wei, Christian Beyer, Jun Liu, Christiane Maier, Chun Li, Thuong Trinh-Minh, Xiaohan Xu, et al. "Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling." Annals of the Rheumatic Diseases 76, no. 4 (February 2, 2017): 773–78. http://dx.doi.org/10.1136/annrheumdis-2016-210294.
Full textOMATA, Masao. "Regression of Liver Fibrosis in Patients Treated By Interferon." Internal Medicine 43, no. 10 (2004): 887–88. http://dx.doi.org/10.2169/internalmedicine.43.887.
Full textWeber, Karl T., Yao Sun, Ivan C. Gerling, and Ramareddy V. Guntaka. "Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease." American Journal of Hypertension 30, no. 11 (April 3, 2017): 1049–52. http://dx.doi.org/10.1093/ajh/hpx054.
Full textBitsch, M., H. H. Nørgaard, O. Røder, T. V. Schroeder, and J. E. Lorentzen. "Inflammatory aortic aneurysms: Regression of fibrosis after aneurysm surgery." European Journal of Vascular and Endovascular Surgery 13, no. 4 (April 1997): 371–74. http://dx.doi.org/10.1016/s1078-5884(97)80078-0.
Full textBoffa, Jean-Jacques, Pierre-Louis Tharaux, Jean-Claude Dussaule, and Christos Chatziantoniou. "Regression of Renal Vascular Fibrosis by Endothelin Receptor Antagonism." Hypertension 37, no. 2 (February 2001): 490–96. http://dx.doi.org/10.1161/01.hyp.37.2.490.
Full textHabib, A., J. Wan, P. Hedge, E. Weiss, A. Brouillet, J. Lodder, R. Moreau, and S. Lotersztajn. "P0426 : Inhibition of monoacylglycerol lipase accelerates liver fibrosis regression." Journal of Hepatology 62 (April 2015): S472—S473. http://dx.doi.org/10.1016/s0168-8278(15)30636-x.
Full textCastera, Laurent. "Non-invasive tests for liver fibrosis progression and regression." Journal of Hepatology 64, no. 1 (January 2016): 232–33. http://dx.doi.org/10.1016/j.jhep.2015.10.011.
Full textChatziantoniou, Christos, Jean-Jacques Boffa, Pierre-Louis Tharaux, Martin Flamant, Pierre Ronco, and Jean-Claude Dussaule. "Progression and regression in renal vascular and glomerular fibrosis." International Journal of Experimental Pathology 85, no. 1 (April 26, 2004): 1–11. http://dx.doi.org/10.1111/j.0959-9673.2004.00376.x.
Full textKitamura, Haruki Kume, Tadaichi. "Spontaneous Regression of Bilateral Hydronephrosis due to Retroperitoneal Fibrosis." Scandinavian Journal of Urology and Nephrology 35, no. 3 (January 2001): 255–56. http://dx.doi.org/10.1080/003655901750292105.
Full textBaggs, R. B., J. Ferin, and G. Oberdörster. "Regression of Pulmonary Lesions Produced by Inhaled Titanium Dioxide in Rats." Veterinary Pathology 34, no. 6 (November 1997): 592–97. http://dx.doi.org/10.1177/030098589703400607.
Full textBozkurt, Devrim, Selahattin Bicak, Savas Sipahi, Huseyin Taskin, Ender Hur, Muhittin Ertilav, Sait Şen, and Soner Duman. "The Effects of Colchicine on the Progression and Regression of Encapsulating Peritoneal Sclerosis." Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28, no. 5_suppl (September 2008): 53–57. http://dx.doi.org/10.1177/089686080802805s11.
Full textJangra, Anshika, Ashish Kothari, Phulen Sarma, Bikash Medhi, Balram Ji Omar, and Karanvir Kaushal. "Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis." Cells 11, no. 9 (April 29, 2022): 1500. http://dx.doi.org/10.3390/cells11091500.
Full textAbdu, Suzan Bakr. "A new perspective in liver fibrosis: Etiology removal does not cause regression of liver fibrosis." Journal of Histology and Histopathology 5, no. 1 (2018): 6. http://dx.doi.org/10.7243/2055-091x-5-6.
Full textPonsoye, Matthieu, Camelia Frantz, Nadira Ruzehaji, Carole Nicco, Muriel Elhai, Barbara Ruiz, Anne Cauvet, et al. "Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis." Annals of the Rheumatic Diseases 75, no. 12 (February 24, 2016): 2142–49. http://dx.doi.org/10.1136/annrheumdis-2015-208213.
Full textSupriono, Supriono, Asri Nugraheni, Handono Kalim, and Mudjiwijono Handaru Eko. "The Effect of Curcumin on Regression of Liver Fibrosis through Decreased Expression of Transforming Growth Factor-β1 (TGF-β1)." Indonesian Biomedical Journal 11, no. 1 (April 30, 2019): 52–8. http://dx.doi.org/10.18585/inabj.v11i1.463.
Full text